Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs continuous interscalene block for proximal humerus fractures
NCT05084573Phase 3Unknown
- Sponsor
- The University of Hong Kong
- Start
- Aug 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liposomal bupivacaine in shoulder fracture, sponsored by The University of Hong Kong. Status: unknown.
02
Drugs
liposomal bupivacaine
03
Conditions
shoulder fracture
Beyond the preview
Go deeper on NCT05084573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05084573.